Patients News | pharmaphorum

News

Samay’s AI-enabled wearable ‘can diagnose COPD’

US start-up Samay has reported clinical data showing that its Sylvee wearable device can accurately diagnose chronic obstructive pulmonary disease (COPD), and even predict

News

Bayer launches support tool for diabetic kidney disease

Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression t

News

X4 cues up FDA verdict in April for WHIM syndrome drug

The FDA has started a priority review of X4 Pharma’s mavorixafor, angling to become the first therapy for the rare disease WHIM syndrome, with a decision due by 30th April

News

MHRA imposes restrictions on acne drug in children

The UK medicines regulator has tightened up controls on the prescription of acne treatment isotretinoin to patients under the age of 18, following a review prompted by con

News

After period of decline, dementia may be on the rise again

While there is widespread fear of an explosion in dementia cases as the global population ages, there has actually been a downward trend in Europe and North America in the

News

EMA finds no evidence GLP-1 agonists cause thyroid cancer

The EMA’s safety committee has said that, after a review of available data, it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’

Samay’s AI-enabled wearable ‘can diagnose COPD’

Bayer launches support tool for diabetic kidney disease

X4 cues up FDA verdict in April for WHIM syndrome drug

MHRA imposes restrictions on acne drug in children

After period of decline, dementia may be on the rise again

EMA finds no evidence GLP-1 agonists cause thyroid cancer

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks